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Abstract
Eczema is a chronic form of childhood disorder that is gaining in prevalence in affluent societies. Previous studies
hypothesized that the development of eczema is correlated with changes in microbial profile and composition of early life
endemic microbiota, but contradictory conclusions were obtained, possibly due to the lack of minimization of apparent
non-health related confounders (e.g., age, antibiotic consumption, diet and mode of delivery). In this study, we recruited
seven caesarean-delivered and total formula-fed infants, and comparatively examined the early-life endemic microbiota in
these infants with and without eczema. Using 16S pyrosequencing, infants’ fecal microbiota were observed to comprise
Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes as the four main phyla, and the presence and absence of
specific populations within these four phyla are primarily mediated by ageing. Quantitative analysis of bacterial targets on a
larger sample size (n=36 at 1, 3, and 12 months of age) revealed that the abundances of Bifidobacterium and
Enterobacteriaceae were different among caesarean-delivered infants with and without eczema, and the bacterial targets
may be potential biomarkers that can correlate to the health status of these infants. Our overall findings suggest that the
minimization of possible confounders is essential prior to comparative evaluation and correlation of fecal microbiota to
health status, and that stool samples collected from caesarean-delivered infants at less than 1 year of age may represent a
good cohort to study for potential biomarkers that can distinguish infants with eczema from those without. These findings
would greatly facilitate future efforts in understanding the possible pathogenesis behind certain bacterial targets, and may
lead to a timely intervention that reduces the occurrence of early life eczema and possibly allergic disorders in later life.
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Introduction
Eczema is a chronic form of childhood disorder that is
characterized by remitting and relapsing cutaneous symptoms.
These symptoms include itching and dryness, flaking, blistering,
oozing, and bleeding. Together with other allergic disorders such as
asthma and allergic rhinitis, the prevalence of eczema has been
increasing globally, particularly in populations with a western
lifestyle [1]. Although allergic disorders like eczema are usually not
life-threatening, they impose considerable health and emotional
burden on the child [2]. Eczema has a multifactorial etiology, and
interaction of genetic factors with the environment has been shown
to play an important role in the pathogenesis of allergic disorders
[3]. Recent studies have also shown that early life endemic
microbiota may play an important role in the subsequent
development of allergic disorders [4,5,6]. For example, past
observations show that in germ-free animal models, the correction
of allergy response by the introduction of conventional gut
microbiota was only achieved in neonates but not in older mice [7].
It is hypothesized that changes in the early life endemic
microbiota may correlate to the health status of the infants. To
understand the role of early life endemic microbiota in modulating
health, their composition in healthy infant gut/feces was first
analyzed through the use of 16S rRNA gene amplicons. Results
suggest that fecal microbiota of infants are made up primarily of
Actinobacteria, Proteobacteria, Firmicutes and Bacteroidetes
[8,9,10]. These microbial groups not only provide for the host’s
metabolic needs but also promote the development of immune
system that may in turn influence health status of the young hosts
[11]. As we gain a better understanding of the endemic microbiota
in healthy infants, it would be pertinent to question the differences
in the endemic microbiota of infants with and without eczema (i.e.,
allergic disorder).
Previous findings have reported that infants with eczema
appeared to have lower microbial diversity in their stools when
compared to healthy controls, suggesting that alteration of the
entire gut/fecal microbiota and the lack of exposure to certain
bacterial targets may be contributing factors that amounted to
their diseased state [12]. Nevertheless, contradictory results which
showed no significant difference in total bacterial profiles of
healthy and diseased infants have also been reported [13].
Comparative semi-quantitative analyses were used to identify
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reached [13,14,15,16]. Some studies reported that infants with
allergic disorders tend to have lower abundance of bifidobacterial
populations and higher proportions of Escherichia coli compared to
the healthy controls [14,15], while other studies showed no distinct
differences in the bifidobacterial populations among infants with
and without allergic disorders [13,16].
One of the main objectives in the Human Microbiome Project
is to determine whether changes in the human microbiome can be
correlated with changes in the health status [4]. A common
approach to address this is to perform a comparative evaluation on
the fecal microbiota of healthy and diseased hosts. However, the
infant fecal microbiota is highly dynamic and subjected to
numerous non-health related confounding factors such as age of
infant, mode of delivery, dietary regime and consumption of
antibiotics [17]. Thus, minimizing the apparent non-health related
confounders would be effective prior to evaluating the correlation
between changes in fecal microbiota and the health status of
infants.
In addition, past studies only monitored microbial succession in
infants with conventional molecular methods like denaturing gel
gradient electrophoresis (DGGE) and SSU rRNA gene-based
microarray [8,9,10] that have their own technical limitations.
DGGE has a detection limit of .1% of the total amplified genes,
and subsequent identification by means of gene sequencing would
only qualitatively denote the presence of predominant groups [18].
Similarly, SSU rRNA gene-based microarray only provides semi-
quantitative detection of bacterial targets, and would not be able to
detect unknown bacterial targets that are not included in the
microarray [19]. Other advanced molecular methods such as 454
pyrosequencing would therefore serve as a better tool to examine
microbial succession.
To systematically address the differences in the microbial
community of infants with and without eczema, this study sampled
stools from seven infants who were delivered via caesarean section
and total-formula fed from birth (Table 1, Text S1). Three were
clinically diagnosed with eczema and the severity assessed by
SCORAD [20]. Using a 16S rRNA-based pyrosequencing [21],
we then analyzed and compared the differences in microbial
succession of these two health groups over four time points (i.e., 1,
3, 12 and 24 months of age), among which the stools from the first
two time points were not affected by antibiotic treatment. All
except one infant received antibiotics at the latter two time points,
but the effect of antibiotic treatment on stool microbiota were kept
to a minimum by sampling for feces at least 1 month after
antibiotic consumption [22]. Through the comparison on the
extent of differences in the microbial profile, we aimed to identify
bacterial targets that were numerically abundant in either of the
health groups, and examined their abundances in a larger infant
cohort (n=36 at 1, 3, and 12 months after birth, respectively) with
a rapid and quantitative molecular tool [23]. These experiments
would allow us to verify if identified potential biomarkers were
representative of health status. The findings would provide a better
understanding to whether differences in fecal microbiota correlate
with the occurrence of eczema, and facilitate future efforts in
understanding the possible pathogenesis behind eczema-related
bacterial targets.
Results
Microbial succession evaluated at phyla level
Microbial diversity and its succession within the seven infants
was examined based on an average 4,396 16S rRNA amplicon
sequences (also termed as 16S pyrotags) per treatment. At 1
month of age, Proteobacteria was detected in feces of all
individuals and accounted for 1.8 to 92.2% of 16S pyrotags. In
particular, Proteobacteria constituted one of the two predominant
phyla that was present in the fecal microbiota of non-eczema
infant C-1 (Figure 1A) and all eczema infants at 1 month of age
(Figure 1B). With increasing age, the proportion of Proteobac-
teria decreased, with the exception of two eczema infants E-2 and
E-3 at 3 months of age (Figure 1B). By the age of 24 months,
Proteobacteria made up less than 1.461.0% of 16S pyrotags.
Firmicutes was another predominant phylum that was present in
Table 1. Clinical data of the seven caesarean-delivered, total-formula-fed infant subjects.
Subject*
Dietary regime
(From birth till 2
years)
Onset of
eczema
SCORAD (month
of diagnosis)
Skin Prick Test
at 1 yr and 2 yr
Total IgE
at 1 yr (kU/L)
Use of antibiotics
(duration before sampling)
C-1 Total-formula N.A. N.A. Negative 3.43 Cotrimoxazole (9 months before 12
months sampling)
Cotrimoxazole (6 months before 24
months sampling)
C-2 Total-formula N.A. N.A. Negative 33.40 Erythromycin and amoxicillin (6 months
before 12 months sampling)
C-3 Total-formula N.A. N.A. Negative 8.03 Azithromycin (3 months before 24
months sampling)
C-4 Total-formula N.A. N.A. Negative 136.00 Nil
E-1 Total-formula 3 months 7.4 (3 months) Positive for inhalant allergens
(Dermatophagoides pteronyssinus)
323.00 Amoxicillin-clavulanic acid (1 month
before 12 months sampling, 7 months
before 24 months sampling)
E-2 Total-formula 6 months 10.9 (6 months) Negative 5.66 Amoxicillin-clavulanic acid (7 months
before 24 months sampling)
Erythromycin (10 months before 24
months sampling)
E-3 Total-formula 1 month 21.2 (1 month)
11.6 (6 months)
Negative 9.60 Amoxicillin-clavulanic acid (12 months
before 24 months sampling)
*Stool samples were obtained from infants with and without eczema, and analyzed for their microbial community using 16S pyrosequencing.
doi:10.1371/journal.pone.0009964.t001
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detected at all time points but its succession varied differently
among individuals. For example, Firmicutes made up 48.9 to
70.2% of 16S pyrotags from the eczema infants at 1 month of
age. Its abundance in the eczema infants rapidly decreased to
11.461.6% at 3 months, and increased again to 73.1+27.5% at
12 months of age. At 24 months, abundances of Firmicutes
decreased in E-1 and E-2 but increased in E-3 (Figure 1).
Actinobacteria consistently remained as the predominant phylum
in three of the non-eczema infants (i.e., C-2, C-3 and C-4) and
accounted for 28.5 to 93.1% of 16S pyrotags at 1 and 3 months
of age. However, it was clearly absent in feces sampled from
eczema infants at 1 and 3 months of age, with the exception of E-
1 at 3 months. At 12 months onwards, the proportion of
Actinobacteria decreased with time for all infants and was
gradually succeeded by Bacteroidetes. The abundance of
Bacteroidetes as observed in C-2, where the abundance decreased
drastically from 68% of 16S pyrotags at 12 months to 2.1% of
16S pyrotags at 24 months of age, was not stable. Verrucomi-
crobia is a rare phylum that was only observed in selected
Figure 1. Microbial succession evaluated at phyla level with 454 pyrosequencing. (A) C-1, C-2, C-3 and C-4 are infants without eczema. (B)
E-1, E-2 and E-3 are infants with eczema. The stools were comprised mainly of phyla Proteobacteria, Actinobacteria, Firmicutes, Bacteroidetes in
varying abundances within each individual and across different temporal intervals. Phyla with abundances more than 5% are marked accordingly.
doi:10.1371/journal.pone.0009964.g001
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point. Similarly, unclassified bacteria only accounted up to 4.3%
of 16S pyrotags.
Microbial succession evaluated at genus level
RDP Classifier was used for taxonomical assignments of the
aligned 16S pyrotags at 95% confidence level. Based on the heat
plot that color-coded the range of abundances (Figure 2), the
phylum Proteobacteria was made up of mainly genera
Citrobacter, Klebsiella, Shigella,a n dEnterobacter,w i t ht h ef i r s tt h r e e
genera detected only in eczema infants but not in non-eczema
infants. This result suggested that although Proteobacteria was
detected consistently in all infants, its composition differed
among eczema and non-eczema infants. The phylum Firmicutes
was made up of various genera like Clostridium, Enterococcus,
Erysipelotrichaceae Incertae Sedis, Faecalibacterium, Lachnospiraceae
Incertae Sedis, Megamonas, Peptostreptococcaceae Incertae Sedis, Strepto-
coccus and Veillonella. At different stages of infancy, different
genera within Firmicutes predominated over others. Phylum
Actinobacteria was made up of only Bifidobacterium and
Collinsella,w i t hBifidobacterium dominating in the early infancy.
Phylum Bacteroidetes consisting of Bacteroides and Parabacteroides
was detected from 12 months onwards, suggesting a maturation
of the gut/fecal microbiota.
Age-related changes in microbial richness and diversity
For individual treatments, rarefraction curves that defined the
numberofoperationaltaxonomicunits(OTUsat97% genesimilarity)
with respect to the number of sequenced 16S pyrotags were plotted
(Figure S1). Regression analysis of the rarefraction curve allows a
subsequent computation of the number of OTUs per treatment that is
identified based on 6,000 16S pyrotags (Table S1). As illustrated in
Figure 3,the number of OTUs increased significantly from 130639 at
1 monthof age to 344681 at 24 months ofage. The numberof OTUs
in eczema infants at 3 months of age was 1.6-fold lower than at 1
month of age, but increased to a similar level as non-eczema infants
after 12 months (P-value=0.716) (Figure 4). Among the non-eczema
infants, C-4 exhibited a different trend in the change of OTUs with
age. For instance, the number of OTUs was consistently low in the
first 12 months, and increased by nearly five-fold to 520 OTUs at 24
months of age. We noted that the infant had high serum total IgE of
136 kU/L (Table 1) at 12 months of age, and speculated that the
raised IgE may be associated with the lower number of OTUs before
12 monthsofage.We matched all OTUsto itsphylogeneticaffiliation,
Figure 2. Color-coded heat plot for the microbial succession evaluated at genera level with 454 pyrosequencing. The color intensity of
the heat plot denotes the average percentage abundance associated with the bacterial target. Control group denotes the four non-eczema healthy
infants, Eczema group denotes the three eczema infants.
doi:10.1371/journal.pone.0009964.g002
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(PCA) that is based on the presence and absence of individual OTUs
in individual samples. A total of 27 dimensions were used to account
for the total variance. The first two dimensions PC1 and PC2, which
accounted for 29.6% of the total variance did not show an apparent
correlation to the eczema status of the infants (Figure 4A). The first
dimension (21.6%) was correlated to age, suggesting that the ageing
process was a relatively domineering factor that mediated changes in
microbial richness and diversity among infants.
Comparison of bacterial lineages and their abundances
in infants
We further compared bacterial lineages and their abundances in
infants at each time point to evaluate if abundances of classified
OTUs correlated with eczema in infants. The PCA results
(Figure 4B) indicate that the first two dimensions accounted for
a total of 91.2% of variance, and a clustering effect based on
health status could be observed along the PC1 dimension. In
particular, non-eczema groups were clustered apart from eczema
groups at 1, 3 and 12 months of age. This suggested that during
early stages of infancy (i.e., below 12 months of age), abundances
of classified OTUs may differentiate infants with eczema from the
healthy matched controls. To further identify bacterial lineages
that were significantly abundant in eczema infants or healthy
controls, the 16S pyrotag libraries were compared in RDP
LibCompare. Bifidobacterium was present at significantly higher
abundance in non-eczema infants compared to those with eczema
at all time points (P-value ,0.001), while Enterococcus, Klebsiella and
Shigella were present at significantly higher abundances in eczema
infants during early stages of infancy (P-value ,0.001).
Abundances of potential biomarkers in vaginal-delivered
infants
A total of 27 vaginal-delivered babies (14 non-eczema controls
and 13 eczema infants) were sampled for their feces at 1, 3 and 12
months of age. To evaluate if Bifidobacterium, Enterococcus and
Enterobacteriaceae (including Klebsiella and Shigella) could serve as
potential biomarkers that are present in different abundances
among eczema and non-eczema infants, their relative abundances
in the collected feces were quantified using a rapid molecular tool
(HOPE, hierarchical oligonucleotide primer extension) developed
for microbial source tracking and community analysis [24,25]. The
results showed that at the time points sampled, the relative
abundances of Bifidobacterium spp. in feces of non-eczema infants
ranged from 17.3 to 33.3%, while the abundances in eczema infants
ranged from 13.7 to 28.5% (Table 2). Although abundances of
genus Bifidobacterium was 1.2 and 1.3-fold higher in non-eczema
infants than eczema infants at 3 and 12 months of age, respectively,
the differences were not significant (P-value=0.35 and 0.17,
respectively) (Table 2). The abundances of individual Bifidobacterium
spp. were also not significantly different among vaginal-delivered
eczema and non-eczema infants (Figure 5A). Similarly, the relative
abundances of Enterococcus and Enterobacteriaceae against the total
Bacteria were not significantly different among vaginal-delivered
infants of both health groups (Table 2).
Abundances of potential biomarkers in caesarean-
delivered babies
A total of 14 caesarean-delivered babies (8 non-eczema controls
and 6 eczema infants) were sampled for their feces at 1, 3 and 12
Figure 3. Individual changes in OTUs in relation to time. The
number of operational taxonomic units (OTUs) defined at 97% similarity
was based on 6000-pyrotag reads. The number of OTUs increased with
age.
doi:10.1371/journal.pone.0009964.g003
Figure 4. Principal component analysis (PCA). (A) PCA was
performed based on the presence and absence of OTUs identified in
each individual at different time-points: upward triangle represents
samples at 1 month; downward triangle represents samples at 3
months; square represents samples at 12 months; kite represents
samples at 24 months. PCA indicated that presence and absence of
OTUs are time-mediated. (B) PCA was performed based on abundance
of classified OTUs within the eczema and non-eczema control health
groups at different time-points. PCA indicated that abundances of
specific bacterial targets correlated to the eczema status of infants
during early stages of infancy.
doi:10.1371/journal.pone.0009964.g004
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Bifidobacterium, Enterococcus and Enterobacteriaceae against the total
Bacteria were quantified. Unlike the vaginal-delivered infants, the
findings suggested that all of the caesarean-delivered eczema
infants had a delayed occurrence of bifidobacterial population that
was only detected at 3 months of age (Table 2). Although relative
abundances of Bifidobacterium against the total Bacteria were not
significantly different among the caesarean-delivered eczema and
non-eczema infants (P-value .0.23), the abundances in the
eczema infants were at least 1.5-fold lower than in the non-
eczema infants (Table 2). Bifidobacterium spp. present in feces of
caesarean-delivered and eczema infants were less diverse than the
non-eczema group at 1 month of age. For example, B. angulatum,
B. adolescentis, B. dentium, the B. catenulatum group, the B. bifidum
group and the B. longum group were only detected in non-eczema
infants at 1 month of age, and accounted for 2.5 to 8.6% of the
total Bacteria (Figure 5B). At 3 months of age, specific Bifidobacterium
spp. like B. dentium and the B. bifidum group were only detected at
an average abundance of 4.2% in non-eczema infants but not in
eczema infants (Figure 5B). At 12 months of age, the relative
abundances of the B. longum group was significantly higher in non-
eczema infants than eczema infants (P-value=0.05) (Figure 5B). In
contrast, at 1 and 3 months of age, the relative abundances of
Enterococcus against the total Bacteria were lower in non-eczema
infants than in eczema infants. The relative abundance of
Enterobacteriaceae was significantly lower in the non-eczema
infants than in eczema infants (P-value=0.02 and 0.01, respec-
tively) (Table 2).
Discussion
This study aims to utilize 16S pyrosequencing to provide an in-
depth analysis of microbial succession in infants. The study also
aims to identify potential bacterial targets that can distinguish
infants with and without eczema. The results reveal that
Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes
constitute the four main phyla in stools sampled from total-
formula-fed and caesarean-delivered infants. Proteobacteria is
generally regarded as the primary colonizer in infants during
delivery, and may originate from the skin microbiota of mothers
Table 2. Comparison of potential biomarkers present in feces of infants as quantified by HOPE.
Vaginal-delivered infants (n=27) Bifidobacterium Enterococcus Enterobacteriaceae
Non-eczema Eczema Non-eczema Eczema Non-eczema Eczema
1 month Frequency of occurrence (%)ˆ 57.1 84.6 64.3 53.8 35.7 38.5
Average abundances
* 21.5624.0 24.7617.0 3.264.3 2.563.7 3.665.5 2.063.2
Ratio of abundances
# 0.87 1.28 1.80
P-value 0.39 0.32 0.36
3 months Frequency of occurrence (%) 92.9 83.3 71.4 50.0 35.7 16.7
Average abundances 33.3618.5 28.5620.7 2.662.9 1.261.8 1.061.5 0.460.9
Ratio of abundances 1.17 2.17 2.50
P-value 0.35 0.09 0.12
12 months Frequency of occurrence (%) 84.6 90.9 53.8 63.6 7.7 0.0
Average abundances 17.3611.5 13.768.0 0.861.1 0.960.8 0.260.7 N.A.
Ratio of abundances 1.26 0.89 N.A.
P-value 0.17 0.31 N.A.
Caesarean-delivered infants (n=14) Bifidobacterium Enterococcus Enterobacteriaceae
Non-eczema Eczema Non-eczema Eczema Non-eczema Eczema
1 month Frequency of occurrence (%) 62.5 0.0 12.5 75.0 12.5 75.0
Average abundances 19.2618.1 N.A. 2.462.5 4.064.8 0.360.8 4.064.4
Ratio of abundances N.A. 0.60 0.08
P-value N.A. 0.27 0.02
6
3 months Frequency of occurrence (%) 75.0 50.0 25.0 100.0 25.0 100.0
Average abundances 26.6620.2 18.4622.1 2.964.0 4.563.9 1.062.1 4.763.2
Ratio of abundances 1.45 0.64 0.21
P-value 0.28 0.32 0.01
12 months Frequency of occurrence (%) 62.5 66.7 62.5 66.7 0.0 16.7
Average abundances 14.0614.6 6.367.6 3.366.1 2.263.9 N.A. 2.766.5
Ratio of abundances 2.22 1.50 N.A.
P-value 0.23 0.50 N.A.
ˆFrequency of occurrence denotes the percentage number of infants who were detected with the bacterial target in their stools.
*Average abundance is obtained by summing up abundances of bacterial target in all individuals of that particular health group, and the total sum divided by the
number of individuals.
#Ratio of abundances is expressed by dividing average abundance of bacterial target in non-eczema group against the eczema-group.
6Underlined P-values indicate significant difference at 95% confidence level.
doi:10.1371/journal.pone.0009964.t002
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Actinobacteria were perceived to be mainly transmitted to infants
from mothers through their vaginal microbiota and breast milk,
respectively [27,28]. Our findings however showed that caesarean-
delivered and total-formula-fed infants also had a microbial
composition that is similar to the vaginal-delivered and breast-fed
infants by 1 month of age, even though they are not exposed to
microorganisms via the conventional vagina and breast-milk
routes. This observation suggests that infants also receive
microorganisms from their mothers during gestation in addition
to mothers’ vaginal microbiota and breast milk as the main sources
of microbial inoculums. Together with other findings which
reported that microorganisms like Bifidobacterium spp. and
Lactobacillus spp. were found to be present in low abundances in
the placenta and meconium of neonates [29,30,31], we think that
gastrointestinal tracts of newborn infants are not as sterile as
previously thought.
It is reported that after the pre-colonization period, different
microorganisms subsequently establish and predominate over a
‘‘conserved and conventional program’’ that is in part mediated by
numerous factors such as age, individual genetics, diet and
environmental settings [9,17]. In addition, there may be other
confounders that can potentially affect microbial succession.
Though delivery mode and diet among all sampled infants were
kept similar, and that the effect of antibiotics treatment were kept
minimal in this study, we could still identify as many as 27
dimensions to account for the total variance that correlated to the
presence and absence of OTUs in infants’ fecal microbiota.
Among them, the age of infant was a significant factor that
accounted for 21.6% of PCA variance (Figure 4A), while other
confounders such as host genetics, consumption of antibiotics,
slight dietary differences during weaning and health status of the
infants may account for small portions of the total PCA variance.
Our findings suggest that the presence and absence of OTUs
did not correlate significantly to the health status of the infants.
The number of unique OTUs identified based on 6000-pyrotags
was not significantly different in the non-eczema and eczema
infants at all time points (Figure 3). Although there was antibiotics
consumption during the late stage of infancy, there was no
observable adverse effect on the OTU increment with time
(Figure 3). This observation seems to suggest the resilience of early
life endemic microbiota in some individuals after short term
antibiotic administration [22,32]. PCA analysis performed using
presence and absence of OTUs suggested that the first dimension
of 21.6% variance could not be related to eczema, but was instead
age-mediated (Figure 4A). These observations are in agreement
with those reported by Penders and coworkers [13], who also did
not observe significant differences in the number of DGGE bands
among non-eczema and eczema infants at 1 month of age.
However, Wang and coworkers [12] reported a significantly lower
microbial diversity in the feces of 1 week old eczema infants than
in healthy subjects by comparing the number of peaks and bands
found on the T-RFLP and TGGE profiles. These contradictory
observations suggest that microbial richness may not be a
Figure 5. Abundances of individual species within the bifidobacterial population as quantified by HOPE. (A) Abundances found in
vaginal-delivered infants (n=27), (B) Abundances found in caesarean-delivered infants (n=14). Abbreviation C stands for non-eczema control infants,
E stands for infants with eczema. * indicates significant differences in the B. longum group found in non-eczema and eczema infants at 12 months of
age.
doi:10.1371/journal.pone.0009964.g005
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non-eczema ones, even after the attempt to minimize non-health
related confounders.
In contrast, PCA analyses performed based on the abundances
of individual OTUs convincingly suggested a strong correlation
between abundances of specific bacterial genera and health status
of the infants during early stages of infancy. Bifidobacterium was
observed to be present at significantly higher abundances in the
caesarean-delivered non-eczema infants than eczema infants, and
vice versa for Enterococcus, Klebsiella and Shigella. This observation
was closely aligned to previous studies [15,33,34,35] that reported
a higher abundance of Bifidobacterium spp. in non-eczema infants
compared to those with eczema, as well as a higher occurrence
frequency of enterococci and Enterobacteriaceae in eczema
infants.
To verify if Bifidobacterium, Enterococcus and Enterobacteriaceae
are potential biomarkers that can be used to distinguish infants
with eczema from those without, their abundances in a larger
sample size were quantified using HOPE. The results suggested
that the abundances of these identified bacterial targets were not
significantly different in the vaginal-delivered non-eczema and
eczema infants. However in caesarean-delivered infants, Entero-
bacteriaceae was found at significantly higher abundances in the
eczema infants compared to non-eczema ones (P-value ,0.02)
(Table 2). Although its abundances were not significantly higher
among the caesarean-delivered non-eczema than eczema infants,
Bifidobacterium was only detected in the non-eczema infants at 1
month of age, and was present in more than 1.4-fold higher
abundance compared to the eczema infants at other time points
(Table 2). The observed difference in abundance of Bifidobacterium
and Enterobacteriaceae in caesarean-delivered infants but not in
vaginal-delivered ones, can possibly explain why probiotics
supplementation would have an effect on the former cohort and
not the latter [36]. As this study only included a limited sample size
for HOPE analysis, future studies with larger sample size will have
to be conducted to provide more conclusive evidence to support
this observation.
Nevertheless, a closer examination of the bifidobacterial
population within the caesarean-delivered infants further showed
differences in relation to the host health status. Among those
caesarean-delivered infants, B. adolescentis group was only detected
in the eczema infants at 3 months of age, but not in the non-
eczema ones (Figure 5B). It is reported that B. adolescentis has lower
adhesive ability compared to other bifidobacterial population, and
this can potentially result in an aberrant endemic microbiota and
its associated immune response in caesarean-delivered eczema
infants [37]. The B. longum group in contrast was only detected in
fecal microbiota of caesarean-delivered non-eczema infants at 1
month of age. Its abundance was also up to 3.8-fold higher in the
stools of non-eczema infants than eczema ones throughout the
sampled period (Figure 5B). These findings suggested that different
species within Bifidobacterium may modulate health status in a
different manner, although overall abundance of this genus is
higher in non-eczema infants than in eczema infants.
This study assumes that a better understanding of the early life
microbiota in relation to the host health status can lead to a timely
intervention that can possibly reduce the occurrence of diseases in
later life. Based on this, eczema and non-eczema infants with
known clinical characteristics were recruited, and their fecal
microbiota were comparatively evaluated with different molecular
tools. We observed that the presence and absence of OTUs in the
fecal microbiota was closely associated with ageing and not to the
infant health status. We further observed that abundances of
specific bacterial lineages (e.g., Bifidobacterium, Enterococcus and
Enterobacteriaceae) were closely associated with the occurrence of
eczema in caesarean-delivered infants after minimization of
apparent non-health related confounders. In particular, stools
collected from caesarean-delivered infants before 12 months of age
may represent a good model to study for potential biomarkers that
can distinguish non-eczema and eczema infants. Future studies
can utilize a similar experimental approach to examine potential
biomarkers in a larger sample size of vaginally-delivered infants.
This would further verify if specific biomarkers are good diagnostic
markers that can identify infants at risk of developing eczema. In
summary, the findings would greatly facilitate future efforts in
understanding the possible pathogenesis behind eczema-related
bacterial targets, and may lead to a timely intervention that
reduces the occurrence of early life eczema and possibly allergic
disorders in later life.
Materials and Methods
Ethics statement
Written informed consent was obtained from all families. The
study was approved by the National University Hospital’s ethics
review committee (Ref Code: B/00/322).
Infant subjects and clinical diagnosis
All subjects recruited for this study were of gestational age above
35 weeks and have a birth weight above 2 kg with no major
congenital malformations or illness at birth. With reference to
Text S1, they belonged to placebo group of the clinical trial
(ClinicalTrials.gov Identifier NCT00318695) and were not
supplemented with probiotics or prebiotics [38]. Eczema was
diagnosed by a doctor, and subjects did not have wheezing,
asthma and allergic rhinitis. SCORAD values were assigned for all
eczema infants [20]. Skin prick tests were performed at 12 and 24
months of age to assess for sensitization to common food and
inhalant allergens. Serum total immunoglobin-E (IgE) was tested
at first year after birth. Information on their respective diet and
antibiotics treatment during the first 2 years of infancy were also
obtained (Table 1). The stool samples examined in this study were
a sub-cohort of the clinical trial, and were carefully chosen by
minimizing potential non-health related confounders (Text S1).
Seven infants who were caesarean-delivered and total formula-fed
were selected to examine for their microbial diversity based on 454
pyrosequencing. Among them, three (E-1, E-2 and E-3) had onset
of eczema in infancy and four (C-1, C-2, C-3 and C-4) were
healthy controls. When assessed for sensitization to common food
and inhalant allergens at 12 and 24 months of age, only E-1
showed sensitization to dust mite allergen (Dermatophagoides
pteronyssinus) at 24 months. To further evaluate for differences in
the abundances of Bifidobacterium spp., Enterococcus spp. and
Enterobacteriaceae, a larger sampling size comprising 19 eczema
infants were also included along with 22 non-eczema controls. All
non-eczema controls were matched for their mode of delivery and
diet regime throughout the sampling duration. The stools were
collected at 1, 3, 12- and 24 months of age based on sampling
procedure as described previously [39].
DNA extraction and PCR
Bacterial DNA from stools was extracted as described previously
[39]. Concentration of bacterial DNA was measured using DU800
spectrophotometer (Beckman Coulter, CA) and diluted to 50 ng/
ml. Samples for 454 FLX pyrosequencing were amplified with
bacterial-specific forward 47F (59-Fusion A-Barcode-CA linker-
GCYTAAYACATGCAAGT-39) and reverse 534R (59-Fusion B-
TC linker-ATTACCGCGGCTGCTGGC-39) primer pairs. A
Fecal Microbiota of Infants
PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e9964total of 28 bar-coded [40] forward primers were used to
differentiate the individual samples. Reaction mixtures comprised
of 100 ng of genomic DNA, 25 ml of Premix F (Epicentre
Biotechnologies, WI), 200 nM (each) of forward and reverse
primers, 0.5 U of Ex Taq DNA polymerase (Takara Bio Inc.,
Japan), and the volume added up to 50 ml with molecular-biology
grade water. PCR with 30 cycles of thermal program (denatur-
ation, 95uC for 30 s; annealing, 50uC for 45 s; and extension,
72uC for 60 s) was performed. Samples for HOPE were amplified
based on protocol described previously with forward 11F [59-GTT
YGA TYC TGG CTC AG-39] and reverse 1492R [59- GGY
TAC CTT GTT ACG ACT T-39] primers [25]. All amplicons
were gel-excised, concentrated and purified with Wizard DNA
purification kit (Promega, WI). The concentrations were then
measured by Qubit fluorometer (Invitrogen, CA) and DU800
(Beckman Coulter, CA).
454 pyrosequencing and pyrosequences alignment
454 pyrosequencing was carried out on 454 Life Science
Genome Sequencer GS FLX (Roche, Switzerland). The services
were provided by Roy J. Carver Biotechnology Center, University
of Illinois at Urbana Champaign. A total of 123,097 pyrotags were
obtained from 454 FLX pyrosequencing run, and each sequence
has an average read length of 230 bp. The 16S pyrotags were
sorted based on their respective barcodes to form a total of 28
pyrotag libraries. All 16S pyrotags were then removed of their
barcodes, linker and fusion adaptor sequences. Two different
alignment schemes were used. The first alignment is based on
NAST which removes non-16S pyrotags in the returned
alignment. As NAST server limits each submission to 500
pyrotags, an individual library was split into smaller subsets
comprising 500 pyrotags, aligned with minimum length set at
200 bp, and with other settings kept at their default values [41].
After NAST alignment, the aligned subset libraries were merged
back into a fasta format. The second alignment is based on RDP
Infernal which allows secondary structure alignment [42]. To
prevent loss of 16S pyrotags from the respective alignment
schemes, we utilize a merge tool available at http://acai.igb.uiuc.
edu/bio/ to merge aligned sequences from both NAST and RDP
Infernal into one alignment file. The merge process further
improves the alignment by replacing the long unaligned portions
of RDP Infernal with the corresponding region from the NAST
alignment. The aligned pyrotags were visually checked with
Jalview: http://www.jalview.org/Web_Installers/install.htm, and
manual adjustments were performed to improve the alignment
whenever necessary.
Taxonomical classification and statistical analysis
RDP Classifier was used for taxonomical assignments of the
aligned 16S pyrotags at 95% confidence level [42]. Primer-E
worksheets that detailed the presence and absence, as well as the
percentage abundances of individual bacterial genera were
collated, and subsequently performed with principal component
analysis on Primer-E software (http://www.primer-e.com/).
Rarefraction curves
Merged alignments were generated with their individual
cluster files based on the RDP pyrosequencing pipeline [42].
The cluster files were in turn used to generate rarefraction
curves that defined the number of operational taxonomic units
(OTUs) defined at 97% similarity level with respect to the total
number of pyrotags read (FigureS 1 ) .R e g r e s s i o na n a l y s i sw a s
also performed on Sigma Plot to fit the rarefraction curves into
double rectangular hyperbola curve models (Table S1). Based
on the curve models, the number of OTUs (97% gene similarity)
identified based on 6000 pyrotags were noted for comparison in
Figure 3.
HOPE
Primers targeting at domain Bacteria, genus Bifidobacterium and its
different clusters, Enterococcus spp., and most Enterobacteriaceae
were arranged into two multiplexing HOPE reaction tubes (Table
S2). HOPE reactions and capillary electrophoresis were carried
out as described previously [23]. Fragment sizes and peak areas of
the extended primers were recorded for subsequent calculation of
the calibration factors (CF) and relative abundances of microbial
targets. Calibration factors (CF) for a lower ranked primer with
respect to a higher ranked primer can be obtained using the M13
amplicons of associated reference strains as template, and
calculated as follow:
CFA{B~
Peak area of extended primer A, Pa
Peak area of extended primer B, Pb
ðiÞ
Where primer B is targeting at a higher hierarchical level com-
pared to primer A.
The relative abundance of 16S rRNA gene amplicons targeted
by the primer A with respect to those targeted by primer B can
then be calculated as follow:
Relative abundance of target % ðÞ
~
Peak area of primer A
Peak area of primer B | CFA{B
|100%
ðiiÞ
Statistical analysis for HOPE data
Mann-Whitney test was used to evaluate for significant
differences in the medians of two groups of data at a confidence
level of 90%. The non-parametric test was performed with
Minitab.
Supporting Information
Text S1 This file describes the selection protocol for infant
subjects.
Found at: doi:10.1371/journal.pone.0009964.s001 (0.04 MB
DOC)
Table S1 Regression analyses of rarefraction curves.
Found at: doi:10.1371/journal.pone.0009964.s002 (0.07 MB
DOC)
Table S2 List of HOPE primers used in this study.
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